Join waitlist

Semaglutide injection sites

Ozempic and Wegovy are approved for three areas: abdomen, front of the thigh, and upper arm. Any of them works — the mistake is using the same spot every week.

Free 3-day trial · no credit card · iOS & Android
✓ You're on the list. One email at launch.
THE APPROVED SITES

Abdomen · thigh · upper arm — rotate between them, and rotate spots within each area. Absorption is equivalent across all three.

Per Ozempic and Wegovy instructions for use, Novo Nordisk. Not medical advice — your prescriber or nurse can demonstrate proper technique.

SEC. 02

What the app does

F—01

Rotate the site

The app remembers where you injected last and suggests where to go next. No more guessing.

F—02

Log the shot

Dose, site, side effects — four seconds, done. Editable forever, exportable for your doctor.

F—03

Shot history

Every injection on a timeline with dose, site and notes — synced to a real account across devices.

F—04

Get reminded

Morning-of, hour-before, and a follow-up if you forget. Weekly doses stop slipping through.

F—05

Set your day

Pick your shot day once. The app builds the week around it — countdown, calendar, history.

F—06

Windows encoded

Missed-dose and change-day rules for your exact medication, built into the schedule logic.

SEC. 03

Q & A

Does the injection site change how well it works?Q—01 +
No — official labeling states absorption is comparable across abdomen, thigh and arm. Comfort and convenience decide.
Why rotate at all?Q—02 +
Repeated injections in one spot can cause lipohypertrophy — lumps under the skin that are sore and can slow absorption.
How does the app help?Q—03 +
It logs each site as part of the 4-second shot log and shows a rotation map with the least-recently-used site suggested next.
When does it launch?Q—04 +
In development now. Waitlist members get first access — US, Canada, UK, Australia and New Zealand, on the App Store and Google Play.

Your next shot,
on time.

One email at launch · free trial · no credit card

No spam — just one launch announcement
✓ You're on the list. Talk soon.